What's Happening?
Three major Parkinson's advocacy organizations are urging Congress to increase funding for Parkinson's research at the National Institutes of Health (NIH). This call comes as Congress reviews the President's federal budget proposal for Fiscal Year 2027,
which includes a $5 billion reduction in NIH funding. The organizations, representing 1.2 million Americans with Parkinson's, are advocating for an increase to $600 million annually for Parkinson's research. This funding level is less than 1% of the annual economic burden of Parkinson's, which totals $82.2 billion. The advocacy groups emphasize the importance of continued federal investment to support scientific breakthroughs and improve treatments for Parkinson's and related neurodegenerative diseases.
Why It's Important?
The potential reduction in NIH funding could slow down critical research progress in Parkinson's disease, affecting millions of Americans. Increased funding is crucial for developing new treatments and potentially finding a cure. The advocacy groups highlight that federal investment has already led to significant advancements in understanding and treating Parkinson's. Maintaining or increasing funding is essential to continue this momentum and address the broader economic impact of the disease. The call for increased funding also reflects public support, as a recent survey shows that three in four voters favor doubling federal investment in Parkinson's research.
What's Next?
The advocacy organizations have mobilized over 300 Parkinson's advocates from 49 states to share their experiences with Congress and push for increased NIH funding. These efforts aim to influence the appropriations process and ensure that the NIH remains a central part of the nation's investment in health and science. The organizations are prepared to support legislative efforts to secure the necessary funding and continue advancing Parkinson's research.
